Dr. Jessica Erin Rexach, MD, PhD

Dr. Rexach practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Rexach's NPI, 1184982027, was assigned on April 29, 2012. Dr. Rexach graduated from David Geffen School of Medicine at UCLA in 2012. Dr. Rexach holds California license A130353.

Dr. Rexach's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Rexach's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Rexach is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Neurology. Dmand AI also links Dr. Rexach to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rexach practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Rexach's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Rexach is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Rexach is licensed in California.

Dmand AI lists alzheimer's disease, non-alzheimer's dementia (chronic) and parkinson's disease among the conditions Dr. Rexach treats.

CMS data shows 100 Medicare services from Dr. Rexach across 3 procedure codes in 2024, for 62 Medicare patients. Medicare paid $10,253 for them.

CMS counts 62 Medicare patients who saw Dr. Rexach in 2024. The largest group is 65 to 74, with 24 patients. 66% of them have high blood pressure, and 63% have high cholesterol. 35% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rexach's median patient age at 58, with 57% women.

In 2024, Dr. Rexach wrote 133 Medicare Part D claims for 26 patients. 92% of them were for generic drugs. CMS names the drug for 75 of them, across 4 drugs with 11 or more claims each, at $1,966 in total drug cost. In 2023, CMS named 47 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Rexach for performance year 2024, reported as part of a group. Dr. Rexach accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rexach as offering telehealth.

Dr. Rexach graduated from David Geffen School of Medicine at UCLA in 2012.

Dr. Rexach is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.